Hyphens Pharma: General Announcement-Hyphens Pharma Launches Ceradan Advanced Hand Balm
Hyphens Pharma: General Announcement-Hyphens Pharma Wins Gold Award for Best Managed Board at Singapore Corporate Awards 2024
Hyphens Pharma: General Announcement-Results Briefing 1H2024
Hyphens Pharma: General Announcement-RESIGNATION OF MR. TIMOTHY CHEN, CEO OF DOCMED TECHNOLOGY AND PAN-MALAYAN PHARMACEUTICALS
Hyphens Pharma: General Announcement-HYPHENS PHARMA LICENSES AMENALIEF FROM MARUHO FOR ASEAN
Hyphens Pharma: General Announcement-Minutes of Annual General Meeting of the Company held on 25 April 2024
Hyphens Pharma: General Announcement-BUSINESS UPDATE FOR THE FIRST QUARTER ENDED 31 MARCH 2024
Hyphens Pharma: Share Buy Back - Daily Share Buy-Back Notice-Daily Share Buy-Back Notice
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: Annual General Meeting-Voluntary
Hyphens Pharma: Share Buy Back - Daily Share Buy-Back Notice-Daily Share Buy-Back Notice
Hyphens Pharma: General Announcement-HYPHENS PHARMA LICENSES WYNZORA CREAM FOR ASEAN COUNTRIES FROM MC2 THERAPEUTICS
Hyphens Pharma: General Announcement-RESULTS BRIEFING FY2023
Hyphens Pharma: General Announcement-HYPHENS PHARMA'S CERADAN RANGE OF PRODUCTS TO ENTER MAJOR MIDDLE EAST MARKETS
Hyphens Pharma: General Announcement-HYPHENS PHARMA PARTNERS 7-ELEVEN TO OFFER OCEAN HEALTH SUPPLEMENTS IN SINGAPORE
Hyphens Pharma: General Announcement-QUARTERLY BUSINESS UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2023
Hyphens Pharma: Asset Acquisitions and Disposals-COMPLETION OF PROPOSED ACQUISITION OF THE TRANCHE 1 SALE SHARES OF 23% IN ARDENCE PHARMA SDN BHD
Hyphens Pharma: General Announcement-ANALYST BRIEFING- ACQUISITION OF ARDENCE MALAYSIA
Hyphens Pharma: Asset Acquisitions and Disposals-PROPOSED ACQUISITION OF 58% OF THE SHARE CAPITAL IN ARDENCE PHARMA SDN BHD OVER 3 TRANCHES
No Data
No Data